3L8-22793-27887
2 vaccinations
3 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 336 / FL
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-22
-
2021-01-29
Survey response — day 14, dose 1MedDRA: Abdominal pain, Nausea — Feeling: GoodFree text: Nausea, mild abdominal pain/cramping.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
-
2021-02-08
Dose 2 — Moderna
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Muscle or body aches, Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-05-10
- 2021-08-09
-
2022-02-08
Survey response — 12 months, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worsening asthma symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-08 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-08 | Unsuccessful |
Free text
Release 3 — day 14, dose 1
Symptoms: Nausea, mild abdominal pain/cramping.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose
Release 11 — 12 months, dose 2
Symptoms: Worsening asthma symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release